We are live on ! Find out more
EBACW

European Biotech Acquisition Corp. Warrant
EBACW

Delisted

EBACW was delisted on the 2nd of March, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in European Biotech Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 32 → 0 (-32)

100% less capital invested

Capital invested by funds: $1.16M → $0 (-$1.16M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 32

Holders
–
Holders Change
-32
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
32
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
Radcliffe Capital Management
Pennsylvania
-$672K
2
AGC
Angelo Gordon & Co
New York
-$135K
3
CS
Clear Street
New York
-$65K
4
PC
Periscope Capital
Ontario, Canada
-$57.6K
5
TCSAM
Tyrus Capital S.A.M.
Monaco
-$39.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
1
Clear Street
New York
– -$65K -217,000 Closed
PC
2
Periscope Capital
Ontario, Canada
– -$57.6K -196,896 Closed
TCSAM
3
Tyrus Capital S.A.M.
Monaco
– -$39.7K -133,332 Closed
MI
4
MMCAP International
Cayman Islands
– -$21.9K -73,525 Closed
SC
5
Sculptor Capital
New York
– -$16.9K -66,666 Closed
RCM
6
Radcliffe Capital Management
Pennsylvania
– -$672K -66,566 Closed
MC
7
Meteora Capital
Florida
– -$14.9K -50,000 Closed
MCM
8
Moore Capital Management
New York
– -$10.4K -41,666 Closed
LA
9
Linden Advisors
New York
– -$10.2K -40,115 Closed
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
– -$9.3K -37,216 Closed
CCM
11
CAAS Capital Management
New York
– -$9.93K -33,333 Closed
Calamos Advisors
12
Calamos Advisors
Illinois
– -$8.33K -33,333 Closed
MTCM
13
Mint Tower Capital Management
Netherlands
– -$10K -33,333 Closed
TCM
14
Tenor Capital Management
New York
– -$9.93K -33,333 Closed
DCM
15
Dupont Capital Management
Delaware
– -$8.33K -33,332 Closed
GF
16
Gabelli Funds
New York
– -$7.28K -24,434 Closed
GCIA
17
Gabelli & Co Investment Advisers
New York
– -$6.53K -21,896 Closed
State of Wisconsin Investment Board
18
State of Wisconsin Investment Board
Wisconsin
– -$5.83K -19,560 Closed
ACA
19
Arena Capital Advisors
California
– -$5.74K -19,251 Closed
WA
20
Whitebox Advisors
Minnesota
– -$5.02K -16,833 Closed
KL
21
KIM LLC
Kansas
– -$4K -16,666 Closed
DC
22
Dryden Capital
Florida
– -$4.47K -15,000 Closed
AA
23
AQR Arbitrage
Connecticut
– -$3.67K -14,666 Closed
OMC
24
Old Mission Capital
Illinois
– -$4.09K -13,742 Closed
AGC
25
Angelo Gordon & Co
New York
– -$135K -13,333 Closed
1
2

EBACW Hedge Fund Activity: Q1 2023 in Review

0 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Warrant (EBACW) for Q1 2023, worth a combined $0 — down 100% from $1.16M a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of EBACW and 0 opened new positions — a net loss of 32 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $672K sold.

  • 0 institutional investors held European Biotech Acquisition Corp. Warrant (EBACW) as of Q1 2023, down from 32 in Q4 2022.
  • Funds reported $0 of European Biotech Acquisition Corp. Warrant stock for Q1 2023, down 100% quarter-over-quarter.
  • 0 funds opened new European Biotech Acquisition Corp. Warrant positions in Q1 2023 and 32 closed out, a net change of -32 holders.
  • The largest European Biotech Acquisition Corp. Warrant seller in Q1 2023 was Radcliffe Capital Management, an estimated $672K sold.

Based on aggregated 13F filings for Q1 2023.